Awareness of involuntary movements in Huntington disease with olanzapine: A case report

Minerva Psichiatrica

Volumn 44, Issue 3, 2003, Pages 189-190

  Fogliani, A M ^a   Di Giorgio, A ^a   Bonomo, V ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Antipsychotic agents; Attitude to health; Huntington disease

Indexed keywords

OLANZAPINE;

ADULT; AGGRESSION; AGITATION; ARTICLE; ATTENTION; CASE REPORT; COGNITIVE DEFECT; CONCENTRATION LOSS; DRUG EFFICACY; FEMALE; HUMAN; HUNTINGTON CHOREA; INSOMNIA; INVOLUNTARY MOVEMENT; MOTOR PERFORMANCE; NEGATIVE SYNDROME; TREATMENT OUTCOME;

EID: 0242611565     PISSN: 03911772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Snowden JS, Craufurd D, Griffiths HL. Awareness of involuntary movements in Huntington disease. Arch Neurol 1998;55:801-5.
2. van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry 1997;63:35-9.
3. Squitieri F, Cannella M, Piorcellini A, Brusa L, Simonelli M, Ruggieri S. Short-term effects of olanzapine in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:69-72.
4. Dallocchio C, Buffa C, Tinelli C, Mazzarello P. Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharmacol 1999;19:101-3.
5. st case report [letter]. J Neurol Neurosurg Psychiatry 1999;67:123-4.
6. Grove VE jr, Quintanilla J, De Vaney GT. Improvement of Huntington's disease with olanzapine and valproate [letter]. N Engl J Med 2000;343:973-4.